Results

Total Results: 2,170 records

Showing results for "share".

281. Final Research Plan: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/final-research-plan-statin-use-primary-prevention-cardiovascular-disease-adults
     November 05, 2020 - Research Plan: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults Share … to Facebook Share to X Share to WhatsApp Share to Email

282. Draft Evidence Review: Nonpregnant Adolescents and Adults: Human Immunodeficiency Virus (HIV) Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-evidence-review-nonpregnant-adolescents-and-adults/human-immunodeficiency-virus-hiv-infection-screening
     November 20, 2018 - Share to Facebook Share to X Share to WhatsApp Share to Email

283. Final Evidence Review: Lung Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/lung-cancer-screening
     March 09, 2021 - Share to Facebook Share to X Share to WhatsApp Share to Email

284. Final Evidence Review: Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/menopausal-hormone-therapy-preventive-medication
     November 01, 2022 - Share to Facebook Share to X Share to WhatsApp Share to Email

285. Final Evidence Review: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication
     June 21, 2022 - Share to Facebook Share to X Share to WhatsApp Share to Email

286. Final Evidence Review: Healthy Weight and Weight Gain In Pregnancy: Behavioral Counseling Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/healthy-weight-and-weight-gain-during-pregnancy-behavioral-counseling-interventions
     May 25, 2021 - Share to Facebook Share to X Share to WhatsApp Share to Email

287. Final Evidence Review: Prediabetes and Type 2 Diabetes in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/prediabetes-type2-diabetes-children-adolescents-screening
     September 13, 2022 - Share to Facebook Share to X Share to WhatsApp Share to Email

288. Final Evidence Review: Hepatitis B Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/hepatitis-b-virus-infection-screening
     December 15, 2020 - Share to Facebook Share to X Share to WhatsApp Share to Email

289. Final Evidence Review: Tobacco Use in Children and Adolescents: Primary Care Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/tobacco-and-nicotine-use-prevention-in-children-and-adolescents-primary-care-interventions
     April 28, 2020 - Share to Facebook Share to X Share to WhatsApp Share to Email

290. Final Evidence Review: Hepatitis B Virus Infection in Pregnant Women: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/hepatitis-b-virus-infection-in-pregnant-women-screening
     July 23, 2019 - Share to Facebook Share to X Share to WhatsApp Share to Email

291. Final Evidence Review: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/breast-cancer-medications-for-risk-reduction
     September 03, 2019 - Share to Facebook Share to X Share to WhatsApp Share to Email

292. Public Comment on Draft Recommendation Statement and Draft Evidence Reviews: Screening for Lead | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-recommendation-statement-and-draft-evidence-reviews-screening-lead
     December 03, 2018 - Comment on Draft Recommendation Statement and Draft Evidence Reviews: Screening for Lead Share … to Facebook Share to X Share to WhatsApp Share to Email

293. Public Comment on Draft Recommendation Statement, Draft Evidence Review, and Draft Modeling Study: Screening for Lung Cancer | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-recommendation-statement-draft-evidence-review-and-draft-modeling-study-screening-lung-cancer
     August 03, 2020 - Statement, Draft Evidence Review, and Draft Modeling Study: Screening for Lung Cancer Share … to Facebook Share to X Share to WhatsApp Share to Email

294. Final Recommendation Statement: Screening for Elevated Blood Lead Levels in Children and Pregnant Women | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/final-recommendation-statement-screening-elevated-blood-lead-levels-children-and-pregnant-women
     April 16, 2019 - Recommendation Statement: Screening for Elevated Blood Lead Levels in Children and Pregnant Women Share … to Facebook Share to X Share to WhatsApp Share to Email

295. Final Recommendation Statement: Screening for Elevated Blood Lead Levels in Children and Pregnant Women | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/final-recommendation-statement-screening-elevated-blood-lead-levels-children-and-pregnant-women-0
     April 16, 2019 - Recommendation Statement: Screening for Elevated Blood Lead Levels in Children and Pregnant Women Share … to Facebook Share to X Share to WhatsApp Share to Email

296. Public Comment on Draft Recommendation Statement and Draft Evidence Review: Behavioral Counseling Interventions to Prevent Sexually Transmitted Infections | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-recommendation-statement-and-draft-evidence-review-behavioral-counseling-interventions-prevent-sexually
     January 21, 2020 - Review: Behavioral Counseling Interventions to Prevent Sexually Transmitted Infections Share … to Facebook Share to X Share to WhatsApp Share to Email

297. Public Comment on Draft Recommendation Statement and Draft Evidence Review: Folic Acid to Prevent Neural Tube Defects | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-recommendation-statement-and-draft-evidence-review-folic-acid-prevent-neural-tube-defects
     March 20, 2023 - Recommendation Statement and Draft Evidence Review: Folic Acid to Prevent Neural Tube Defects Share … to Facebook Share to X Share to WhatsApp Share to Email

298. Public Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Atrial Fibrillation | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/uspstf/uspstf/uspstf/announcements/draft-recstatement-atrial-fibrillation-screening
     May 17, 2021 - Recommendation Statement and Draft Evidence Review: Screening for Atrial Fibrillation Share … to Facebook Share to X Share to WhatsApp Share to Email

299. First Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services - Figure 3 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/first-annual-report-to-congress-on-high-priority-evidence-gaps-for-clinical-preventive-services---figure-3
     December 01, 2011 - Share … to Facebook Share to Twitter Share to WhatsApp … Share to E-mail Print Current Stakeholder Engagement Points

300. First Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services - Figure 2 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/first-annual-report-to-congress-on-high-priority-evidence-gaps-for-clinical-preventive-services---figure-2
     December 01, 2011 - Share … to Facebook Share to Twitter Share to WhatsApp … Share to E-mail Print Stages in USPSTF Recommendation Development